AimwellBio (AIMN) is building the Federated Health Intelligence Network - and preparing to introduce the physicians, scientists and healthcare experts whose knowledge deserves greater visibility.MIAMI, FL / ACCESS Newswire / July 27, 2026 / Aimwell Partners Inc. (OTCID:AIMN), parent company of Aimw…
Credentialed biopharma professionals can now access AimwellBio's Observer tier at no cost, while the company publishes the Adversarial Validation Standard, v1-the methodology behind every verified intelligence output.MIAMI, FL / ACCESS Newswire / July 22, 2026 / Aimwell Partners, Inc (OTCID:AIMN) T…
MIAMI, FL / ACCESS Newswire / July 15, 2026 / Aimwell Partners Inc. (OTCID:AIMN), parent company of AimwellBio, today confirmed it is engaged in advanced discussions with an exclusive, referral-based life sciences capital markets network that connects biotechnology companies with institutional inve…
MIAMI, FL / ACCESS Newswire / July 8, 2026 / Aimwell Partners Inc. (OTCID:AIMN) - Technology adoption rarely begins with procurement. It begins with the professionals doing the work.Analysts, regulatory affairs specialists, clinical researchers, and scientific leaders discover tools that improve th…
